Survival for non functioning neuroendocrine tumours (NETs) of the pancreas depends on many different factors. So you should only use these statistics as a guide.

Doctors usually work out the outlook for a certain disease by looking at large groups of people. Because non functioning NETs of the pancreas are so rare, the survival for this disease is harder to estimate than for other, more common cancers.

These are general statistics based on small groups of people. Remember, they can’t tell you what will happen in your individual case.

Your specialist doctor can give you more information about your own outlook (prognosis).

You can also talk about this with the Cancer Research UK nurses on freephone 0808 800 4040, from 9am to 5pm, Monday to Friday.

What affects survival

Survival depends on many factors. It depends on the stage and grade of the tumour when it was diagnosed. The stage describes the size of the tumour and whether it has spread. The grade means how abnormal the cells look under a microscope.

Another factor is how well you are overall. 

Survival for non functioning NETs of the pancreas

There are no UK survival statistics for non functioning NETs of the pancreas. The statistics below are from an American study. Please be aware that due to differences in health care systems, data collection and the population, these figures may not be a true picture of survival in the UK. 

Around 30 out of every 100 people (30%) survive non functioning NETs of the pancreas for 5 years or more.

Almost 20 out of every 100 people (20%) survive non functioning NETs of the pancreas for 10 years or more.

Survival for NETs of the pancreas

In the UK, no statistics are available for the survival of all the different types of pancreatic NETs. This is because researchers haven’t collected this information yet. The information we have here is the 1 year survival for all types of pancreatic NETs.

This information is from people diagnosed in England between 2013-2015. Because this is for England only, it might not be the same for the whole of the UK.

Around 80 out of every 100 people (80%) diagnosed with a pancreatic NET survive for 1 year or more. 

About these statistics

The term 1 year, 5 year and 10 year survival does not mean that you will only live for 1, 5 or 10 years. They relate to the number of people who are still alive 1 year, 5 years or 10 years after their diagnosis.

Some people live much longer than 10 years.

Last reviewed: 
04 Jul 2019
  • Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
    T Halfdanarson and others
    Annals of Oncology, 2008. Vol 19, Pages 1727-1733

  • Cancer: Principles and Practice of Oncology (10th edition)
    VT DeVita, TS Lawrence, SA Rosenberg
    Lippincott, Williams and Wilkins, 2015

  • 1-Year survival rates for neuroendocrine tumour patients in England
    T Genus and others
    Public Health England, 2017

  • ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
    M Falconi and others
    Neuroendocrinology, 2016. Vol 103, Pages 153–171

Related links